US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. June 29, 2021

    Bankrupt Purdue Pitches $5.39M Exec Payment Plan

    Purdue Pharma asked a New York bankruptcy court Monday to approve the OxyContin drugmaker's 2021 employee incentive and retention plans, which propose to pay its top five executives up to $5.39 million this year, with its general counsel receiving a seven-figure pay package.

  2. June 16, 2021

    Examiner With Narrow Scope Approved In Purdue Ch. 11

    A New York bankruptcy judge begrudgingly approved the appointment of an examiner in the Chapter 11 case of OxyContin maker Purdue Pharma LP on Wednesday, saying he was doing so only because the baseless allegations included in the examiner motion needed to be addressed publicly.

  3. June 14, 2021

    Purdue Hits Back At Creditor's Motion For Ch. 11 Examiner

    Bankrupt OxyContin maker Purdue Pharma LP attacked a creditor's motion seeking the appointment of a Chapter 11 examiner, telling a New York judge that the creditor's arguments that the debtor's owners steamrolled the company into accepting a $4.5 billion settlement are baseless and would threaten the debtor's proposed Chapter 11.

  4. June 03, 2021

    Purdue Asks To Extend Opioid Suit Shield To End Of Summer

    Purdue Pharma has asked a New York bankruptcy judge for a 75-day extension on an injunction pausing suits over opioid sales against it and its owners, the Sackler family, saying they need protection as they "sprint" to the confirmation of Purdue's Chapter 11 plan.

  5. May 26, 2021

    Purdue Statement Gives Creditors Enough Info, Judge Says

    A New York bankruptcy judge gave a preliminary nod Wednesday to Purdue Pharma's Chapter 11 plan disclosures, but held off on an approval order after the drugmaker said it needed to clear up some disputes and add a few details to the statement.

  6. May 24, 2021

    Purdue's New Ch. 11 Plan Docs Detail Claims Trust Framework

    Bankrupt drug manufacturer Purdue Pharma LP filed an amended Chapter 11 plan and supporting documents Monday in New York court that provide details on how $1.4 billion in distributions will be shared by different groups of claimants in the case.

  7. May 20, 2021

    Purdue Says It May Have To Push Back Ch. 11 Schedule

    Drugmaker Purdue Pharma told a New York bankruptcy judge Thursday that it may not be able to keep to the schedule it set for its Chapter 11 case, saying it is hitting some "intractable" issues as it negotiates the terms of its restructuring.

  8. May 12, 2021

    Purdue's Ch. 11 Confirmation Hearing Set For August

    A New York bankruptcy judge on Wednesday approved a motion setting an August date for Purdue Pharma's Chapter 11 plan confirmation hearing, assuming the drugmaker's plan disclosure statement is approved next week.

  9. May 07, 2021

    Purdue Asks For Another Month's Hold On Opioid Suits

    Purdue Pharma is asking a New York bankruptcy judge for another 27-day extension of an injunction freezing opioid suits against the company and its owners, saying it needs more time to ensure it gets court approval for its Chapter 11 plan disclosures.

  10. April 27, 2021

    Newborn Opioid Victim Group Says Purdue Docs Lack Info

    A group representing the interests of victims of neonatal abstinence syndrome in the bankruptcy case of opioid maker Purdue Pharma told a New York judge late Monday that the debtor's Chapter 11 plan documents don't provide enough information about their treatment.